When should Ureaplasma testing be performed in adult men, which specimens and nucleic‑acid amplification test are preferred, and what are the first‑line treatment options?

Ureaplasma Testing in Males

Routine testing for Ureaplasma in adult men is not recommended because asymptomatic colonization is extremely common (34–63% of healthy sexually active men) and does not require treatment. 1, 2, 3

When Testing Is NOT Indicated

• Do not test asymptomatic men without urethritis symptoms, as Ureaplasma colonization is part of normal urogenital flora in sexually active males and detection does not change management 1, 2, 3

• Do not test men with mild urethritis symptoms (< 5 polymorphonuclear leukocytes per oil-immersion field on urethral smear) until you have excluded Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma genitalium, and Trichomonas vaginalis first 1, 3, 4

• Avoid multiplex PCR panels that automatically include Ureaplasma testing alongside traditional STI pathogens, as this leads to unnecessary treatment and antimicrobial resistance 3

When Testing MAY Be Considered (After Excluding Other Pathogens)

Testing for Ureaplasma should only occur in the following narrow circumstances:

1. Persistent Non-Gonococcal Urethritis

• Test only when: Patient has documented urethritis with ≥5 polymorphonuclear leukocytes per oil-immersion field on urethral Gram stain AND all of the following have been ruled out: N. gonorrhoeae, C. trachomatis, M. genitalium, and T. vaginalis 1, 3

• Severe urethritis threshold: Ureaplasma urealyticum (not U. parvum) shows association with urethritis only when inflammation is severe (>30 polymorphonuclear leukocytes per high-power field) 4

• U. parvum distinction: Ureaplasma parvum colonizes men with no or mild urethritis and should not be treated even if detected 4

2. Pre-Urologic Instrumentation

• Screen and treat asymptomatic Ureaplasma before any urologic procedure that breaches the mucosa (transurethral resection, prostate biopsy, cystoscopy) to prevent post-procedural infection 2

3. Male Infertility Evaluation (Controversial)

• A 2025 meta-analysis found U. urealyticum and M. hominis associated with male infertility, but not U. parvum or M. genitalium 1

• However, treatment does not reliably improve conception rates or live birth outcomes—only sperm parameters may improve, which does not translate to fertility 1, 2

• Testing may be considered in couples with unexplained infertility after standard evaluation, but set realistic expectations about treatment benefit 1

Preferred Specimen and Testing Method

Specimen Collection

• First-void urine (10–20 mL of initial stream) is the preferred non-invasive specimen for nucleic acid amplification testing (NAAT) 1

• Urethral swab is acceptable but more invasive; insert swab 2–4 cm into urethra and rotate 1

• Semen sample may be used in infertility evaluation 1

Testing Methodology

• Quantitative species-specific NAAT is strongly preferred over culture because it can distinguish U. urealyticum (potentially pathogenic in high loads) from U. parvum (usually commensal) 3, 4

• Culture is less sensitive and does not provide quantitative data, but may be used if NAAT is unavailable 1

• High bacterial load threshold: Only men with high U. urealyticum load (>10⁴ CFU/mL) should be considered for treatment, as lower loads likely represent carriage 3, 4

First-Line Treatment (When Indicated)

• Doxycycline 100 mg orally twice daily for 7 days is the preferred regimen based on uniform susceptibility 1, 2

• Alternative: Erythromycin base 500 mg orally 4 times daily for 7 days if doxycycline is contraindicated 1

• Azithromycin 1.0–1.5 g single dose has poor efficacy due to high resistance rates (≈66% in M. hominis) and should be avoided 2

• For persistent symptoms after doxycycline: Extend erythromycin to 14 days to cover tetracycline-resistant U. urealyticum 1

Partner Management

• Treat sexual partners who had contact within the preceding 60 days when the index patient has symptomatic urethritis requiring treatment 2

• Do not treat partners of asymptomatic men who were tested only for pre-procedural screening 2

Common Pitfalls to Avoid

• Testing without symptoms: 40–80% of detected Ureaplasma cases represent asymptomatic carriage, not infection requiring treatment 3, 5, 6

• Treating U. parvum: This species causes minimal urethral inflammation and should not be treated even when detected 4

• Skipping traditional STI testing: Always exclude gonorrhea, chlamydia, M. genitalium, and trichomonas before attributing urethritis to Ureaplasma 1, 3

• Using non-quantitative tests: Without bacterial load quantification, you cannot distinguish pathogenic infection from colonization 3, 4

• Expecting fertility improvement: Treatment may improve sperm parameters but has not been proven to increase pregnancy or live birth rates 1, 2